Stockhouse cannabis sector investors have watched Canada’s domestic companies take a sometimes rickety rollercoaster ride over the past 12 to 18 months. But the nausea that cannabis can often effectively treat patients can’t necessarily help with the motion sickness investors have felt watching their stocks tumble in the face of a myriad problems licensed producers, cultivators and retailers have faced, and created, over that time.
As a result, savvy investors in the cannabis space are beginning to look outside the box, errr borders, for bona fide opportunities in places some may consider off the beaten path. Like…Latin America.
Did you know that Canada was not the first country to legalize recreational, adult-use cannabis at the federal level? In fact, the South American country of Uruguay passed legislation to legalize recreational cannabis in December 2013, making it the first country in the modern era to legalize cannabis (almost 5 years prior to Canada). Fast- forward to today and you’ll find that Colombia has positioned itself as the newest major player on the Latin American cannabis landscape.
According to Prohibition Partners, Latin America is among the world’s fastest-growing cannabis markets with expected cannabis spending of USD$12-billion by 2028, and an estimated 68 million potential medicinal cannabis patients.
Colombia started along a path toward legalization in 1986, and now has one of the most sophisticated regulatory systems in the continent. The country boasts an ideal climate for cultivation of the plant, tolerant legislation, and low production costs that have recently turned the South American nation into a major hub for international cannabis investments. Today, the local industry is dominated by a few players that have attracted investor attention above others.
One such player is Blueberries Medical Corp. (BBM) (CSE: BBM, OTC: BBRRF, FRA: 1OA, Forum) – a Latin American licensed producer of medicinal cannabis and cannabis-derived products, operating mainly out of the Bogotá Savannah of central Colombia.
Commencing trading on the Canadian Securities Exchange in February 2019, BBM has quickly gained the attention of both public retail and private institutional investment communities in South and North America, as reported in a Stockhouse Top Value Stock Editorial in June.
This innovative Colombian-based company has distinction of being the first Company to have designed and engineered a machine with new stainless-steel extraction vessels that is fully compliant under European Union’s Good Manufacturing Practices (EU-GMP). They also boast 142 exclusive Colombian cannabis strains with high CBD and THC contents with all of the applicable licenses granted by the Colombian Ministries of Justice and Health.
Blueberries Medical Corp. has made a number of strategic moves over the past 18 months to help grow its business and brand globally. Stockhouse investors who’ve traditionally kept a keen eye to North American-only cannabis companies, may want to take a long, hard look at this value opportunity stock.
FULL DISCLOSURE: Blueberries Medical Corp. is a paid client of Stockhouse Publishing.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.
Let’s block ads! (Why?)